Integrating Biosimilars into Chronic Disease Treatment Plans

Biosimilars, akin to their originator biologics, offer a promising avenue for addressing the complex needs of individuals battling chronic illnesses

Lupin Secures EIR from US FDA For its Nagpur Unit

Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Nagpur Unit-1 manufacturing facility that...

Everest Medicines Bags TFDA Approval To Treat Intra-abdominal Infections

Everest Medicines, a biopharmaceutical company focused on the development, manufacturing, and commercialization of novel medicines and vaccines, announced that the Taiwan Food and Drug Administration (TFDA) has approved the New Drug Applica...

Sun Pharma In the Process of Buying out local partner in Mexican arm

Sun Pharmaceutical Industries Ltd announced an MXN 161.85 million (about Rs 75 crore) acquisition of local partner Indi Pharma from its Mexican branch. Sun Pharmaceutical Industries stated in a regulatory filing that it has signed a binding letter...

Mycobacterium Tuberculosis Testing Market To Grow at 4% CAGR

The market for mycobacterium tuberculosis tests in India is expected to grow at a compound annual growth rate of 4% between 2023 and 2033 as the country works to combat tuberculosis, a persistent global health challenge that continues to...

Saluda Medical Secures US FDA Approval For Evoke System MRI labelling

The US Food and Drug Administration (FDA) has authorized MRI conditional labeling for the Evoke System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy driven by SmartLoop technology according to...

NMPA Nods AffaMed Therapeutics Clinical Trial application For dry AMD

AffaMed Therapeutics, a global biotechnology company, announced that China's National Medical Products Administration has approved AffaMed’s Clinical Trial Application (CTA) to investigate the efficacy and safety of risuteganib (Luminate), its...

Kyverna, ElevateBio Join Hands To Advance CAR T-cell Therapies

Kyverna Therapeutics, a clinical-stage cell therapy company focused on engineering a new class of therapies for serious autoimmune diseases, and ElevateBio, LLC, a technology-driven company focused on powering transformative cell and gene...

Sun Pharma Unveils Novel Topical Treatment

PRWINLEVI is now accessible in Canada, according to Sun Pharma Canada Inc. According to the company, WINLEVI is the first and only androgen receptor inhibitor approved for the topical treatment of acne vulgaris (acne) in patients 12 and older...

Pharma Sector Must Focus On Innovation To Become Global Leader Says Mansukh Mandaviya

Mansukh Mandaviya, Union Health Minister, has urged the indigenous Pharma Sector to focus on the research and development of novel goods in order to progress up the value chain and reach global leadership. Mandaviya, who also owns the Chemicals...

© 2024 India Pharma Outlook. All Rights Reserved.